Home » Authors » Nuala Moran

Articles by Nuala Moran

HUPO Formed To Capitalize On Genome, Advance Proteomics

Feb. 20, 2001

KS Biomedix Moves Lead Drug Into Phase IIb, Eyes Pivotal Trial

Feb. 14, 2001

Antisoma Planning Financing To Stay Ahead, Keep Flexibility

Feb. 14, 2001

Oxford Glyco Plans Gaucher NDA On Cerezyme Comparison Study

Feb. 14, 2001

Acambis Achieves Early Results That Validate Flavivirus Vaccine

Feb. 14, 2001

British Biotech's Marimistat Fails In Promising Indication

Feb. 14, 2001

Oxford Glyco Plans Gaucher NDA On Cerezyme Comparison Study

Feb. 14, 2001

Acambis Achieves Early Results That Validate Flavivirus Vaccine

Feb. 14, 2001

KS Biomedix Moves Lead Drug Into Phase IIb, Eyes Pivotal Trial

Feb. 14, 2001

Antisoma Planning Financing To Stay Ahead, Keep Flexibility

Feb. 14, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...